Quantification of increased biologically active CXCL12α plasma concentrations after ACKR3 antagonist treatment in humans.
Saved in:
| Title: | Quantification of increased biologically active CXCL12α plasma concentrations after ACKR3 antagonist treatment in humans. |
|---|---|
| Authors: | Blattmann, Peter1 (AUTHOR) peter.blattmann@idorsia.com, Farine, Hervé1 (AUTHOR), Dan, Brian1 (AUTHOR), Stiffler, Nicole1 (AUTHOR), Lefebvre, Thomas1 (AUTHOR), Huynh, Christine1 (AUTHOR), Sidharta, Patricia N.1 (AUTHOR), Dingemanse, Jasper1 (AUTHOR), Welford, Richard W. D.1 (AUTHOR), Keller, Marcel1 (AUTHOR), Strasser, Daniel S.1 (AUTHOR) daniel.strasser@idorsia.com |
| Source: | CTS: Clinical & Translational Science. Feb2024, Vol. 17 Issue 2, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
